Disease on EC 3.4.23.3 - gastricsin and Organism(s) Homo sapiens and UniProt Accession P20142
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Achlorhydria
Gastric emptying and first-pass metabolism of ethanol in elderly subjects with and without atrophic gastritis.
Achlorhydria
Low acid output in Pima Indians. A possible cause for the rarity of duodenal ulcer in this population.
Acquired Immunodeficiency Syndrome
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.
Adenocarcinoma
Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomas.
Adenocarcinoma
Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma.
Adenocarcinoma
HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Adenocarcinoma
Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
Adenocarcinoma
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
Adenocarcinoma
The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.
Adenocarcinoma
[The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
Adenoma
[The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
Anemia
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.
Anemia
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
Anemia, Pernicious
Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
Anemia, Pernicious
Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
Anemia, Pernicious
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
Anemia, Pernicious
Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese.
Arthritis, Juvenile
[METHOD FOR DETERMINING EROSIVE LESIONS OF THE GASTRIC MUCOUSA IN CHILDREN WITH JUVENILE ARTHRITIS].
Aspermia
The concentration of pepsinogen C in human semen and the physiological activation of zymogen in the vagina.
Barrett Esophagus
Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
Barrett Esophagus
Pepsinogen C: a possible biological marker of epithelial differentiation in Barrett's esophagus.
Breast Cyst
Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
Breast Diseases
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Breast Diseases
Isolation and characterization of a pepsin C zymogen produced by human breast tissues.
Breast Neoplasms
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Breast Neoplasms
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas.
Breast Neoplasms
Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.
Breast Neoplasms
Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.
Breast Neoplasms
Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone.
Breast Neoplasms
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
Breast Neoplasms
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Breast Neoplasms
Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters.
Breast Neoplasms
Overall survival in women with breast cancer: the influence of pepsinogen C gene polymorphism.
Breast Neoplasms, Male
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Carcinogenesis
PGC TagSNP and its interaction with H. pylori and relation with gene expression in susceptibility to gastric carcinogenesis.
Carcinogenesis
Polymorphic rs9471643 and rs6458238 upregulate PGC transcription and protein expression in overdominant or dominant models.
Carcinoma
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Carcinoma
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas.
Carcinoma
Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.
Carcinoma
Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma.
Carcinoma
Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids.
Carcinoma
Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit.
Carcinoma
Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
Carcinoma
Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
Carcinoma
Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Carcinoma
Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Carcinoma
Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.
Carcinoma
[An immunohistochemical study of pepsinogen type C in the gastric mucosa and in stomach cancer]
Carcinoma, Ductal
Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
Carcinoma, Hepatocellular
Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study.
Carcinoma, Intraductal, Noninfiltrating
Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
Carcinoma, Ovarian Epithelial
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas.
Carcinoma, Squamous Cell
Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids.
Cysts
Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.
Cysts
Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
Dehydration
Effects of long-term dehydration on oxidative stress, apoptotic markers and neuropeptides in the gastric mucosa of the dromedary camel.
Diabetes Mellitus
Hypergastrinemia in obese noninsulin-dependent diabetes: a possible reflection of high prevalence of vagal dysfunction.
Duodenal Ulcer
Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Duodenal Ulcer
Different effects of H. pylori water extracts on cytokines, pepsinogen C and gastrin mucosal release in patients with or without duodenal ulcer.
Duodenal Ulcer
Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers.
Duodenal Ulcer
Effect of proximal gastric vagotomy on serum pepsinogen I and II concentrations and acid secretion in duodenal ulcer patients.
Duodenal Ulcer
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
Duodenal Ulcer
Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Duodenal Ulcer
Genetic heterogeneity of combined gastric and duodenal ulcers detected by pepsinogen C gene polymorphism.
Duodenal Ulcer
Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Duodenal Ulcer
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
Duodenal Ulcer
Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
Duodenal Ulcer
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?]
Esophageal Squamous Cell Carcinoma
Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit.
Gallbladder Neoplasms
[Immunohistochemical demonstration of pepsinogens I and II in the gallbladder]
Gallstones
Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.
Gastritis
Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis.
Gastritis
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Gastritis
HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Gastritis
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Gastritis
Helicobacter pylori: prevalence, transmission, and serum pepsinogen II concentrations in children of a poor periurban community in Bangladesh.
Gastritis
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.
Gastritis
Low acid output in Pima Indians. A possible cause for the rarity of duodenal ulcer in this population.
Gastritis
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.
Gastritis
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
Gastritis
Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
Gastritis
Serological parameters in assessment of degree of gastritis in healthy volunteers.
Gastritis
Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese.
Gastritis
Serum levels of pepsinogen I, pepsinogen II, and gastrin-17 in the course of Helicobacter pylori gastritis in pediatrics.
Gastritis
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Gastritis
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Gastritis
Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.
Gastritis
Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.
Gastritis
[Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication]
Gastritis
[Serum pepsinogen response to therapy for Helicobacter pylori associated gastro-duodenal disease]
Gastritis, Atrophic
Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.
Gastritis, Atrophic
Effects of polyunsaturated fatty acids on atrophic gastritis in a Japanese population.
Gastritis, Atrophic
Free and protein-bound cobalamin absorption in healthy middle-aged and older subjects.
Gastritis, Atrophic
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.
Gastritis, Atrophic
Gastric emptying and first-pass metabolism of ethanol in elderly subjects with and without atrophic gastritis.
Gastritis, Atrophic
Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
Gastritis, Atrophic
Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17.
Gastritis, Atrophic
Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Gastritis, Atrophic
Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men.
Gastritis, Atrophic
Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Gastritis, Atrophic
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran.
Gastritis, Atrophic
Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.
Gastritis, Atrophic
The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan.
Gastritis, Atrophic
The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.
Gastritis, Atrophic
The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.
Gastritis, Atrophic
The Risk of Helicobacter Pylori Infection and Atrophic Gastritis from Food and Drink Intake: a Cross-sectional Study in Hokkaido, Japan.
Gastrointestinal Diseases
Ultrasensitive detection of pepsinogen I and pepsinogen II by a time-resolved fluoroimmunoassay and its preliminary clinical applications.
Infections
A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
Infections
Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Infections
Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection.
Infections
Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Infections
Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Infections
Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
Infections
Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection.
Infections
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Infections
Differences in the levels of gastric cancer risk factors between Nanjing and Minqing counties, China.
Infections
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
Infections
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.
Infections
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Infections
Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis.
Infections
Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.
Infections
Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study.
Infections
Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
Infections
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.
Infections
Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients.
Infections
Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Infections
Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort.
Infections
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Infections
Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men.
Infections
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.
Infections
Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.
Infections
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
Infections
The Risk of Helicobacter Pylori Infection and Atrophic Gastritis from Food and Drink Intake: a Cross-sectional Study in Hokkaido, Japan.
Infections
The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology.
Infections
[Interaction between an insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection in the development of gastric cancer]
Infections
[Seroepidemiological study on Helicobactor pylori infection in rural adult residents]
Infertility, Male
The concentration of pepsinogen C in human semen and the physiological activation of zymogen in the vagina.
Lymphatic Metastasis
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Lymphatic Metastasis
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
Melanoma
Expression and clinical significance of pepsinogen C in uveal melanomas.
Melanoma
Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters.
Neoplasm Metastasis
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Neoplasm Metastasis
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
Neoplasm Metastasis
[Immunohistochemical demonstration of pepsinogens I and II in the gallbladder]
Neoplasm Metastasis
[Immunohistologic detection of pepsin and gastricsin in carcinoma of the stomach]
Neoplasms
A case of intraductal papillary mucinous neoplasm with high serum pepsinogen II level.
Neoplasms
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Neoplasms
Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
Neoplasms
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Neoplasms
Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.
Neoplasms
Correlations of gastrointestinal hormones with inflammation and intestinal flora in patients with gastric cancer.
Neoplasms
Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells.
Neoplasms
Expression and clinical significance of pepsinogen C in uveal melanomas.
Neoplasms
Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.
Neoplasms
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Neoplasms
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
Neoplasms
Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.
Neoplasms
Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor.
Neoplasms
Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study.
Neoplasms
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
Neoplasms
pS2 protein in gastric carcinoma and normal gastric mucosa: association with clincopathological parameters and patient survival.
Neoplasms
Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.
Neoplasms
Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
Neoplasms
The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Neoplasms
[The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
Nevus, Pigmented
Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters.
Overweight
Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer.
Pancreatic Cyst
Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.
Pancreatic Neoplasms
Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.
Peptic Ulcer
Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection.
Peptic Ulcer
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Peptic Ulcer
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Peptic Ulcer
Prospective study of the effect of gastrectomy with and without bile reflux on serum pepsinogens.
Peptic Ulcer
Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
Peptic Ulcer
[Pepsin and gastricsin secretion in the course of digestion in peptic ulcer and in health]
Persistent Infection
Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study.
Precancerous Conditions
Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population.
Precancerous Conditions
PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases.
Precancerous Conditions
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Prostatic Hyperplasia
The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Prostatic Neoplasms
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Prostatic Neoplasms
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Prostatic Neoplasms
The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Starvation
Regulation of progastricsin mRNA levels in sea bass (Dicentrarchus labrax) in response to fluctuations in food availability.
Starvation
Spontaneous pepsin C-catalyzed activation of human pepsinogen C in transgenic rice cell suspension culture: Production and characterization of human pepsin C.
Stomach Diseases
Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
Stomach Diseases
Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.
Stomach Diseases
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
Stomach Diseases
LncRNAs adjacent to pepsinogen C in gastric diseases and diagnostic efficiencies of joint detection in gastric diseases.
Stomach Neoplasms
Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.
Stomach Neoplasms
Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer.
Stomach Neoplasms
Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer.
Stomach Neoplasms
Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
Stomach Neoplasms
Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
Stomach Neoplasms
Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
Stomach Neoplasms
Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.
Stomach Neoplasms
Correlation between the prevalence of gastritis and gastric cancer in Japan.
Stomach Neoplasms
Correlations of gastrointestinal hormones with inflammation and intestinal flora in patients with gastric cancer.
Stomach Neoplasms
Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.
Stomach Neoplasms
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
Stomach Neoplasms
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.
Stomach Neoplasms
Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Stomach Neoplasms
Expression and prognostic significance of pepsinogen C in gastric carcinoma.
Stomach Neoplasms
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Stomach Neoplasms
Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease.
Stomach Neoplasms
Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants.
Stomach Neoplasms
Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population.
Stomach Neoplasms
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.
Stomach Neoplasms
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
Stomach Neoplasms
Pepsinogen C expression-related lncRNA/circRNA/mRNA profile and its co-mediated ceRNA network in gastric cancer.
Stomach Neoplasms
Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort.
Stomach Neoplasms
Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
Stomach Neoplasms
PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases.
Stomach Neoplasms
Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients.
Stomach Neoplasms
Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II.
Stomach Neoplasms
RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation.
Stomach Neoplasms
Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea.
Stomach Neoplasms
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran.
Stomach Neoplasms
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Stomach Neoplasms
The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.
Stomach Neoplasms
[Correlation between an insertion-deletion polymorphism in the pepsinogen C gene and gastric cancer as well as its precursors]
Stomach Neoplasms
[Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects]
Stomach Neoplasms
[Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area]
Stomach Neoplasms
[Interaction between an insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection in the development of gastric cancer]
Stomach Neoplasms
[Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
Stomach Ulcer
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
Stomach Ulcer
Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Stomach Ulcer
Genetic heterogeneity of combined gastric and duodenal ulcers detected by pepsinogen C gene polymorphism.
Stomach Ulcer
Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
Stomach Ulcer
The expression of pepsinogen c mRNA in normal gastroduodenal mucosa and the gastric ulcer margin of the rat.
Stomach Ulcer
[Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication]
Vitamin B 12 Deficiency
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.